L&K Biomed Ltd. (KOSDAQ: 156100)

Market Cap	131.78B
Revenue (ttm)	30.50B
Net Income (ttm)	664.93M
Shares Out	19.94M
EPS (ttm)	34.09
PE Ratio	193.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,093
Open	6,560.00
Previous Close	6,620.00
Day's Range	6,560.00 - 6,820.00
52-Week Range	5,890.00 - 10,950.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants worldwide. It offers anterior and expandable lateral lumber cage systems; cervical interbody fusion cage, anterior cervical plate system, posterior cervical fixation system; spinal fixation screw, lumber plate, and spinal fixation systems, as well as posterior lumber interbody cage. The company also provides lateral and anterior lumber interbody cage, and transforaminal lumber interbody cage; MIS spinal and spinal fixation systems; and SI joint fusion system. L&K Biomed ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 60
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100

Financial Performance

In 2023, L&K Biomed's revenue was 29.90 billion, an increase of 51.28% compared to the previous year's 19.77 billion. Losses were -1.87 billion, -86.30% less than in 2022.